跳至主要内容
临床试验/RPCEC00000323
RPCEC00000323招募中未知

TRANSFUSION WITH CONVALING PLASMA IMMUNIZES THE ASYMPTOMATIC PATIENT WITH COVID INFECTION 19 THAT FOR MORE THAN 30 DAYS IS POSITIVE SARS CoV-2 PCR (COVID-19)

Institute of Hematology and Immunology Dr. Jose Manuel Ballester Santovenia”0 个研究点开始时间: 2020年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
19 years 至 74 years(—)
性别
All

入选标准

  • 1. Adult with SARS-CoV2 infection diagnosed by RT-PCR.
  • 2. Remain asymptomatic with SARS-CoV2 positive PCR for more than 30 days.
  • 3. That the antibody kit tests do not detect antibodies.
  • 4. That there is no history of anaphylaxis reactions with blood products.
  • 5. That at the clinical evaluation by the attending physician there are no contraindications for plasma transfusion.
  • 6. That the patient or their relatives give their informed consent to receive this donation.

排除标准

  • 未提供

研究者

发起方
Institute of Hematology and Immunology Dr. Jose Manuel Ballester Santovenia”

相似试验